Market Data
Pricing
Solutions
Log In
Market Overview
Financials
Asset Management
Parent Companies
Taizhou Huaxin Pharmaceutical Investment Co Ltd
Huaxin Pharmaceutical Hong Kong Co Ltd
2024-1
Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2024-1
HYC
FNCL
HAXNP 2024-1 (USD 60m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
ABC
,
CEB
,
CTC
,
CMC
,
...
APAC
Jan 11, 2024
Missing something? Tell us.